Episodes

  • NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.

    NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.
    Jan 21 2026
    Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne’eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.
    Show More Show Less
    14 mins
  • NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.

    NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.
    Jan 14 2026
    Tara Sklar is the faculty director of the Health Law and Policy Program at the University of Arizona James E. Rogers College of Law and associate director of telehealth law and policy at the University of Arizona College of Medicine–Tucson Arizona Telemedicine Program. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Sklar and B. Richman. Financing Telehealth — Moving Beyond Payment Parity. N Engl J Med 2026;394:211-213.
    Show More Show Less
    12 mins
  • NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.

    NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.
    Jan 7 2026
    Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668.
    Show More Show Less
    11 mins
  • NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.

    NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.
    Dec 31 2025
    Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3.
    Show More Show Less
    10 mins
  • NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.

    NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.
    Dec 17 2025
    Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.
    Show More Show Less
    8 mins
  • NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

    NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
    Dec 10 2025
    Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.
    Show More Show Less
    10 mins
  • NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.

    NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.
    Dec 3 2025
    Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.
    Show More Show Less
    15 mins
  • NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.

    NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.
    Nov 26 2025
    Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080.
    Show More Show Less
    12 mins